Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
Pyrexia Reports for Zoster Live (Zostavax)
#4 most reported symptom for this vaccine
Pyrexia and Zoster Live (Zostavax)
Pyrexia has been reported 17,849 times in association with Zoster Live (Zostavax) vaccination in VAERS. This represents 12.7% of all 140,312 reports for this vaccine.
Among these reports, 24 mentioned death (0.13%) and 448 involved hospitalization (2.5%).
Pyrexia is the #4 most frequently reported symptom for Zoster Live (Zostavax) out of 2827 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
What This Means
Seeing 17,849 reports of Pyrexia after Zoster Live (Zostavax) vaccination may seem alarming, but context is critical. With 140,312 total reports for this vaccine (representing many millions of doses), Pyrexia appears in only 12.7% of reports.
The mortality rate among these reports is very low at 0.13%, suggesting most cases are non-fatal.
Important Context
Quick Facts
Related Pages
Data Source
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.